Bartlett & Co Wealth Management’s Mettler-Toledo International MTD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56K Sell
2
-1
-33% -$1.21K ﹤0.01% 1145
2026
Q1
$3.78K Hold
3
﹤0.01% 1048
2025
Q4
$4.18K Hold
3
﹤0.01% 1038
2025
Q3
$3.68K Buy
+3
New +$3.76K ﹤0.01% 1040
2024
Q2
Sell
-1
Closed -$1.33K 1162
2024
Q1
$1.33K Buy
+1
New +$1.23K ﹤0.01% 1060
2022
Q4
Sell
-6
Closed -$6.5K 1167
2022
Q3
$6.5K Sell
6
-16
-73% -$19.9K ﹤0.01% 884
2022
Q2
$25.3K Buy
+22
New +$27.6K ﹤0.01% 688
2019
Q1
Sell
-8
Closed -$4.53K 749
2018
Q4
$4.53K Hold
8
﹤0.01% 626
2018
Q3
$4.87K Sell
8
-7
-47% -$4.12K ﹤0.01% 641
2018
Q2
$8.68K Hold
15
﹤0.01% 603
2018
Q1
$8.63K Buy
+15
New +$9.43K ﹤0.01% 624

Other funds holding MTD

Bartlett & Co Wealth Management's MTD Position: Q2 2026 in Review

Bartlett & Co Wealth Management reduced its Mettler-Toledo International (MTD) stake by 33% in Q2 2026, selling an estimated $1.21K and leaving 2 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Bartlett & Co Wealth Management first reported a position in MTD in Q1 2018 and has held it in 11 quarters since. The position peaked at $25.3K in Q2 2022. 798 funds tracked by Wall St. Rank hold MTD as of Q2 2026.

  • Bartlett & Co Wealth Management held 2 shares of Mettler-Toledo International worth $2.56K as of Q2 2026.
  • Bartlett & Co Wealth Management sold 1 Mettler-Toledo International share in Q2 2026, an estimated $1.21K.
  • Mettler-Toledo International made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #1145 holding.
  • Bartlett & Co Wealth Management first reported a position in Mettler-Toledo International in Q1 2018 and has held it in 11 quarters since.
  • Bartlett & Co Wealth Management's Mettler-Toledo International position peaked at $25.3K in Q2 2022.
  • 798 funds tracked by Wall St. Rank held Mettler-Toledo International as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.